DHA sbir phase 1 proposal H242-001-0085, "innovative DNA for highly multiplexed molecular diagnostics"
Ended Purchase Order Awarded Last action
- Contract number
- HT942525P0010
- Awardee
-
Firebird Biomolecular Sciences LLC UEI CTWDPXTLUAM7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $249,957
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $249,956.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 16 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Santa Fe, FL 32615, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $249,957 |
About this award
The Defense Health Agency awarded a $249,956.88 Small Business Innovation Research Phase 1 contract to Firebird Biomolecular Sciences LLC for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics." The firm-fixed-price purchase order, set aside for small businesses, was awarded on October 9, 2024, with performance completion targeted for May 8, 2025. Firebird Biomolecular Sciences LLC, a small business specializing in advanced molecular diagnostics and biotechnology research based in Alachua, Florida, will leverage its expertise in nucleic acid innovations and molecular engineering to advance diagnostic capabilities under this contract.
The project focuses on developing rapid, point-of-care diagnostic tests utilizing electrochemical detection methods, with particular emphasis on coronavirus detection including COVID-19. This SBIR Phase 1 award represents continued investment by the Defense Health Agency in innovative diagnostic technologies and aligns with the company's established track record of federal research funding from agencies including the National Institutes of Health and Department of Energy, where Firebird has previously developed advanced molecular constructs and coronavirus detection reagents. The contract deliverables will support the Department of Defense's interest in maintaining cutting-edge diagnostic capabilities for disease detection and response.
Quick answers
Who was awarded contract HT942525P0010?
HT942525P0010 was awarded to Firebird Biomolecular Sciences LLC by Defense Health Agency (Department of Defense) on October 9, 2024.
How much is contract HT942525P0010 worth?
The government has obligated $249,957 on HT942525P0010.
Was contract HT942525P0010 competed?
The extent of competition for HT942525P0010 was full and open competition after exclusion of sources. The government received 16 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award